1. Home
  2. RVPH vs IH Comparison

RVPH vs IH Comparison

Compare RVPH & IH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RVPH
  • IH
  • Stock Information
  • Founded
  • RVPH 2006
  • IH 1996
  • Country
  • RVPH United States
  • IH China
  • Employees
  • RVPH N/A
  • IH N/A
  • Industry
  • RVPH Biotechnology: Pharmaceutical Preparations
  • IH Other Consumer Services
  • Sector
  • RVPH Health Care
  • IH Real Estate
  • Exchange
  • RVPH Nasdaq
  • IH Nasdaq
  • Market Cap
  • RVPH 88.0M
  • IH 96.9M
  • IPO Year
  • RVPH N/A
  • IH 2020
  • Fundamental
  • Price
  • RVPH $1.84
  • IH $1.86
  • Analyst Decision
  • RVPH Strong Buy
  • IH
  • Analyst Count
  • RVPH 5
  • IH 0
  • Target Price
  • RVPH $11.40
  • IH N/A
  • AVG Volume (30 Days)
  • RVPH 1.6M
  • IH 21.6K
  • Earning Date
  • RVPH 11-14-2024
  • IH 02-27-2025
  • Dividend Yield
  • RVPH N/A
  • IH 4.52%
  • EPS Growth
  • RVPH N/A
  • IH N/A
  • EPS
  • RVPH N/A
  • IH 0.28
  • Revenue
  • RVPH N/A
  • IH $134,002,994.00
  • Revenue This Year
  • RVPH N/A
  • IH $15.90
  • Revenue Next Year
  • RVPH N/A
  • IH $8.64
  • P/E Ratio
  • RVPH N/A
  • IH $6.65
  • Revenue Growth
  • RVPH N/A
  • IH N/A
  • 52 Week Low
  • RVPH $0.60
  • IH $1.47
  • 52 Week High
  • RVPH $4.50
  • IH $2.48
  • Technical
  • Relative Strength Index (RSI)
  • RVPH 47.68
  • IH 64.32
  • Support Level
  • RVPH $1.66
  • IH $1.69
  • Resistance Level
  • RVPH $2.14
  • IH $1.70
  • Average True Range (ATR)
  • RVPH 0.15
  • IH 0.08
  • MACD
  • RVPH -0.02
  • IH 0.02
  • Stochastic Oscillator
  • RVPH 36.73
  • IH 96.30

About RVPH Reviva Pharmaceuticals Holdings Inc.

Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, and Parkinson's disease psychosis and its other drug candidate is RP1208.

About IH iHuman Inc.

iHuman Inc is a Chinese company that uses artificial intelligence to create technology-driven puzzle products for children, making parenting easier and children happier. The company offers a range of intellectual development products that are designed to make the child-rearing experience more manageable for parents while turning intellectual development into a fun journey for children. Its revenue is generated from subscription fees paid by users for premium content on their self-directed and interactive online applications, as well as offline products and other sources. The majority of iHuman Inc's revenue comes from mainland China.

Share on Social Networks: